India-Based Pharmaceutical Companies See Growing Need for Focused Medical Affairs Functions
CHAPEL HILL, N.C. – Jan 3, 2014 - Across the global healthcare landscape, the Medical Affairs function is essential for meeting a variety of challenges. Successful Medical Affairs groups often thrive because their organization realizes that they provide extremely valuable services. Despite this, groups within the Indian Pharmaceutical industry are still rapidly evolving and are struggling to show the value of their Medical Affairs functions.
Medical Affairs continues to grow into a global function, with emerging markets increasingly seeing the need for and importance of focused Medical Affairs functions. Recent research from benchmarking firm, Best Practices, LLC even found that 89% of Indian benchmarked companies now have a dedicated Medical Affairs group in their organization. As the healthcare environment becomes increasingly competitive, the role of Medical Affairs in India will become more and more critical.
The report, "Building Best-in-Class Medical Affairs Capabilities In India- A Case Study For High-Growth Emerging Markets," provides leaders with comparative metrics, executive insights, and best practices from Medical Affairs professionals throughout the industry. The research also illustrates how leading Global and Indian pharmaceutical and medical device companies structure and organize their Medical Affairs functions.
Key study topics include:
- Medical Affairs Scope & Structure
- Leadership & Oversight
- Regulatory Landscape & Challenges
- Spend Allocations & Investment Benchmarks
- Staffing Benchmarks
- Functional Responsibility & Service
- Budget Trends & Success Factors
This benchmarking research drew participation from 68 benchmark survey respondents from 50 companies. In addition, research analysts conducted in-depth interviews with 7 respondents to collect qualitative data and insights.
To access the full report or to download a complimentary summary containing insights found in this report, click here.
For more information on other recent primary research studies, contact us at 919.403.0251 or visit our website at http://www.best-in-class.com.